Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS)

Journal of Immunotoxicology

Volumn 8, Issue 1, 2011, Pages 30-38

  Zheng, Li ^a   Dong, Guang Hui ^a   Zhang, Ying Hua ^a   Liang, Zai Fu ^a   Jin, Yi He ^a,b   He, Qin Cheng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

antibody; Perfluorooctanesulfonate; T helper cells; Type 1 cytokine; Type 2 cytokine

Indexed keywords

CORTICOSTERONE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PERFLUOROOCTANESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENVIRONMENTAL EXPOSURE; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNE STATUS; IMMUNOMODULATION; IMMUNOTOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ALKANESULFONIC ACIDS; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; MALE; MICE; MICE, INBRED C57BL; SPLEEN; TH1 CELLS; TH2 CELLS;

MUS;

EID: 79751520130     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.3109/1547691X.2010.537287     Document Type: Article

References (43)

1. Alexander, B. H., Olsen, G. W., Burris, J. M., Mandel, J. H. and Mandel, J. S. 2003. Mortality of employees of a perfuorooctanesulphonyl fuoride manufac-turing facility. Occup. Environ Med. 60:722-729. (Pubitemid 37203427)
2. Austin, M. E., Kasturi, B. S., Barber, M., Kannan, K., MohanKumar, P. S. and MohanKumar, S. M. 2003. Neuroendocrine efects of perfuorooctane sulfonate in rats. Environ. Health Perspect 111:1485-1489. (Pubitemid 37120827)
3. Berghella, A. M., Contasta, I., Pellegrini, P., Del Beato, T. and Adorno, D. 2006. Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? Cancer Biother. Radiopharm. 21:468-487. (Pubitemid 44747605)
4. Bermejo-Martin, J. F., Ortiz de Lejarazu, R., Pumarola, T., Rello, J., Almansa, R., Ramírez, P., Martin-Loeches, I., Varillas, D., Gallegos, M. C., Serón, C., Micheloud, D., Gomez, J. M., Tenorio-Abreu, A., Ramos, M. J., Molina, M. L., Huidobro, S., Sanchez, E., Gordón, M., Fernández, V, Del Castillo, A., Marcos, M. A., Villanueva, B., López, C. J., Rodríguez-Domínguez, M., Galan, J. C., Cantón, R., Lietor, A., Rojo, S., Eiros, J. M., Hinojosa, C., Gonzalez, I., Torner, N., Banner, D., Leon, A., Cuesta, P., Rowe, T. and Kelvin, D. J. 2009. T1 and T17 hypercytokinemia as early host response signature in severe pandemic infuenza. Crit Care. 13:R201.
5. Boonstra, A., Rajsbaum, R., Holman, M., Marques, R., Asselin-Paturel, C., Pereira, J. P., Bates, E. E., Akira, S., Vieira, P., Liu, Y. J., Trinchieri, G. and O'Garra, A. 2006. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88-and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177:7551-7558. (Pubitemid 44846270)
6. Burris, J. M., Lundberg, J. K., Olsen, G. W., Simpson, C., and Mandel, J. H. 2002. Determination of Serum Half-lives of Several Fluorochemicals. Interim Report #2. St Paul, MN:3M Company. U.S. EPA docket AR-226-1086. Washington, DC: U.S. Environmental Protection Agency.
7. Butenhof, J. L., Olsen, G. W. and Pfahles-Hutchens, A. 2006. Te applicability of biomonitoring data for perfuorooctanesulfonate to the environmen-tal public health continuum. Environ. Health Perspect. 114:1776-1782. (Pubitemid 44718286)
8. Calafat, A. M., Kuklenyik, Z., Reidy, J. A., Caudill, S. P., Tully, J. S. and Needham, L. L. 2007. Serum concentrations of 11 polyfuoroalkyl com-pounds in the u.s. population: Data from the national health and nutrition examination survey (NHANES). Environ. Sci. Technol. 41:2237-2242. (Pubitemid 46595180)
9. de Vos, M. G., Huijbregts, M. A., van den Heuvel-Greve, M. J., Vethaak, A. D., Van de Vijver, K. I., Leonards, P. E., van Leeuwen, S. P., de Voogt, P. and Hendriks, A. J. 2008. Accumulation of perfuorooctane sulfonate (PFOS) in the food chain of the Western Scheldt estuary: Comparing feld measure-ments with kinetic modeling. Chemosphere 70:1766-1773. (Pubitemid 351173250)
10. Dewitt, J. C., Copeland, C. B., Strynar, M. J. and Luebke, R. W. 2008. Perfuorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ. Health Perspect. 116:644-650. (Pubitemid 351864281)
11. Dong, G. H., Zhang, Y. H., Zheng, L., Liu, W., Jin, Y. H. and He, Q. C. 2009. Chronic efects of perfuorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch. Toxicol. 83:805-815.
12. Fietta, P. and Delsante, G. 2009. Te efector T-helper cell triade. Riv. Biol. 102:61-74.
13. Francis, J., MohanKumar, S. M. and MohanKumar, P. S. 2000. Correlations of norepinephrine release in the paraventricular nucleus with plasma cor-ticosterone and leptin after systemic lipopolysaccharide: Blockade by soluble IL-1 receptor. Brain Res. 867:180-187. (Pubitemid 30317395)
14. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoué, F., Bruneval, P., Cugnenc, P. H., Trajanoski, Z., Fridman, W. H. and Pagès, F. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964. (Pubitemid 44498003)
15. Giesy, J. P. and Kannan, K. 2001. Global distribution of perfuorooctane sul-fonate in wildlife. Environ. Sci. Technol. 35:1339-1342. (Pubitemid 32862501)
16. Gilliland, F. D. and Mandel, J. S. 1993. Mortality among employees of a per-fuorooctanoic acid production plant. J. Occup. Med. 35:950-954. (Pubitemid 23285042)
17. 1 mice. J. Toxicol. Sci. 34:687-691.
18. Hansen, K. J., Clemen, L. A., Ellefson, M. E. and Johnson, H. O. 2001. Compound-specifc, quantitative characterization of organic fuorochem-icals in biological matrices. Environ. Sci. Technol. 35:766-770. (Pubitemid 32173716)
19. 2a. J. Immunol. 163:4175-4181. (Pubitemid 29474480)
20. Houde, M., Bujas, T. A., Small, J., Wells, R. S., Fair, P. A., Bossart, G. D., Solomon, K. R. and Muir, D. C. 2006. Biomagnifcation of perfuoroalkyl compounds in the bottlenose dolphin (Tursiops truncatus) food web. Environ. Sci Technol. 40:4138-4144. (Pubitemid 44161666)
21. Jin, Y., Saito, N., Harada, K. H., Inoue, K. and Koizumi, A. 2007. Historical trends in human serum levels of perfuorooctanoate and perfuorooctane sul-fonate in Shenyang, China. Tohoku J. Exp. Med. 212:63-70. (Pubitemid 46711727)
22. Kulmatycki, K. M. and Jamali, F. 2001. Terapeutic relevance of altered cytokine expression. Cytokine 14:1-10. (Pubitemid 32579267)
23. Lall, S. B. and Dan, G. 1999. Role of corticosteroids in cadmium induced immu-notoxicity. Drug Chem. Toxicol 22:401-409. (Pubitemid 29203007)
24. Lefebvre, D. E., Curran, I., Armstrong, C., Coady, L., Parenteau, M., Liston, V, Barker, M., Aziz, S., Rutherford, K., Bellon-Gagnon, P., Shenton, J., Mehta, R. and Bondy, G. 2008. Immunomodulatory efects of dietary potassium perfuorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats. J. Toxicol. Environ. Health Part A 71:1516-1525.
25. Mosser, D. M. and Zhang, X. 2008. Interleukin-10: New perspectives on an old cytokine. Immunol. Rev. 226:205-218.
26. O'Garra, A. and Vieira, P. 2004. Regulatory T-cells and mechanisms of immune system control. Nat Med. 10:801-805. (Pubitemid 39070850)
27. H1 cells control themselves by producing interleukin-10. Nat Rev. Immunol. 7:425-428. (Pubitemid 46834852)
28. OECD (Organization for Economic Co-operation and Development). 2002. Hazard Assessment of Perfuorooctane Sulfonate (PFOS) and Its Salts. Available at http://www.oecd.org/dataoecd/23/18/2382880.pdf.
29. Peden-Adams, M. M., Keller, J. M., Eudaly, J. G., Berger, J., Gilkeson, G. S. and Keil, D. E. 2008. Suppression of humoral immunity in mice following exposure to perfuorooctane sulfonate. Toxicol. Sci. 104:144-154. (Pubitemid 351859037)
30. 2. Proc. Natl. Acad. Sci. USA 85:6880-6884.
31. Qazi, M. R., Bogdanska, J., Butenhof, J. L., Nelson, B. D., DePierre, J. W. and Abedi-Valugerdi, M. 2009a. High-dose, short-term exposure of mice to perfuorooctanesulfonate (PFOS) or perfuorooctanoate (PFOA) afects the number of circulating neutrophils diferently, but enhances the infammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262:207-214.
32. Qazi, M. R., Xia, Z., Bogdanska, J., Chang, S. C., Ehresman, D. J., Butenhof, J. L., Nelson, B. D., DePierre, J. W. and Abedi-Valugerdi, M. 2009b. Te atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfuorooc-tanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-α (PPARα). Toxicology 260:68-76.
33. Reichlin, S. 2004. Neuroendocrinology of acute immunity. J. Endocrinol. Invest. 27:48-61.
34. H2 subsets in PBMC from advanced cancer patients. Anticancer Res. 18:3951-3955. (Pubitemid 28561086)
35. Seacat, A. M., Tomford, P. J., Hansen, K. J., Clemen, L. A., Eldridge, S. R., Elcombe, C. R. and Butenhof, J. L. 2003. Sub-chronic dietary toxicity of potassium perfuorooctanesulfonate in rats. Toxicology 183:117-131. (Pubitemid 36005393)
36. Shakhar, G. and Blumenfeld, B. 2003. Glucocorticoid involvement in sup-pression of NK activity following surgery in rats. J. Neuroimmunol. 138:83-91. (Pubitemid 36566421)
37. Spiegelberg, H. L. 1990. Te role of interleukin-4 in IgE and IgG subclass forma-tion. Springer Semin. Immunopathol 12:365-383.
38. 4 secretion in vivo. Clin. Exp. Immunol. 84:400-405.
39. Yang, Q., Abedi-Valugerdi, M., Xie, Y., Zhao, X. Y., Möller, G., Nelson, B. D. and DePierre, J. W. 2002a. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome prolif-erator, perfuorooctanoic acid. Int Immunopharmacol. 2:389-397. (Pubitemid 34075427)
40. Yang, Q., Xie, Y and Depierre, J. W. 2000. Efects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol. 122:219-226.
41. Yang, Q., Xie, Y., Alexson, S. E., Nelson, B. D. and DePierre, J. W. 2002b. Involvement of the peroxisome proliferator-activated receptor-α in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol 63:1893-1900. (Pubitemid 34603454)
42. Yang, Q., Xie, Y., Eriksson, A. M., Nelson, B. D. and DePierre, J. W. 2001. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxi-some proliferator perfuoroctanoic acid in mice. Biochem. Pharmacol. 62:1133-1140. (Pubitemid 32971679)
43. Zheng, L., Dong, G. H., Jin, Y H. and He, Q. C. 2009. Immunotoxic changes associated with a 7-day oral exposure to perfuorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch. Toxicol. 83:679-689.